Design, synthesis, and biological evaluation of multiple targeting antimalarials
Yiqing Yang(Tsinghua University), Yu Rao(Soochow University), Zhenghui Huang(Beijing Chao-Yang Hospital, Capital Medical University), Lubin Jiang(Chinese Academy of Sciences), Mulaka Maruthi(University of Hyderabad), Brigitte Meunier(Bodmin Hospital), Jing Zhou(Inner Mongolia Electric Power (China)), Thomas Michel(Brigham and Women's Hospital), Hangjun Ke(Drexel University), Xiaolu Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Liguo Wang(Beijing Tongren Hospital), Yue Wu(Tsinghua University), Tongke Tang(Shanghai University), Liqin Ling(Mount Sinai Hospital), Hongying Gao(Tsinghua University)
Cited by 16
Related Papers
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2023|892
PROTACs: great opportunities for academia and industry
|Signal Transduction and Targeted Therapy|2019|627
A Worldwide Map of<i>Plasmodium falciparum</i>K13-Propeller Polymorphisms
|New England Journal of Medicine|2016|574